EMEA-001988-PIP01-16-M01
Key facts
| Invented name |
GHRYVELIN (previously Macimorelin Aeterna Zentaris)
|
| Active substance |
Macimorelin
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0076/2020
|
| PIP number |
EMEA-001988-PIP01-16-M01
|
| Pharmaceutical form(s) |
Granules for oral solution
|
| Condition(s) / indication(s) |
Diagnosis of growth hormone deficiency
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Aeterna Zentaris GmbH
E-mail: macrilen@aezsinc.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|